Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Pfizer
Numab Therapeutics AG
Mundipharma Research Limited
ADC Therapeutics S.A.
pharmaand GmbH
Tesaro, Inc.
Jerome Canady Research Institute for Advanced Biological & Technological Sciences
Alliance for Clinical Trials in Oncology
Takeda
Masonic Cancer Center, University of Minnesota
National Institutes of Health Clinical Center (CC)
Merrimack Pharmaceuticals
National Cancer Institute (NCI)
INSYS Therapeutics Inc
Case Comprehensive Cancer Center